SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-021983
Filing Date
2020-02-14
Accepted
2020-02-14 17:00:27
Documents
1
Period of Report
2019-12-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm205737d3_4.html 4  
1 OWNERSHIP DOCUMENT tm205737d3_4.xml 4 5733
  Complete submission text file 0001104659-20-021983.txt   7514
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS, INC. 3 UNIVERSITY PLAZA DRIVE, SUITE 320 HACKENSACK NJ 07601
Business Address
Polverino Anthony J. (Reporting) CIK: 0001729957 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36641 | Film No.: 20621554